The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-((R)-3-amino-2-oxo-3-(4-((2-(trifluoromethyl)quinolin-4-yl)methoxy)phenyl)pyrrolidin-1-yl)-N-hydroxy-4-methylpentanamide ID: ALA3221857
PubChem CID: 90668114
Max Phase: Preclinical
Molecular Formula: C27H29F3N4O4
Molecular Weight: 530.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C[C@H](C(=O)NO)N1CC[C@@](N)(c2ccc(OCc3cc(C(F)(F)F)nc4ccccc34)cc2)C1=O
Standard InChI: InChI=1S/C27H29F3N4O4/c1-16(2)13-22(24(35)33-37)34-12-11-26(31,25(34)36)18-7-9-19(10-8-18)38-15-17-14-23(27(28,29)30)32-21-6-4-3-5-20(17)21/h3-10,14,16,22,37H,11-13,15,31H2,1-2H3,(H,33,35)/t22-,26-/m1/s1
Standard InChI Key: KQNNPPBFBXDAIH-ATIYNZHBSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
12.2889 -5.7718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6992 -5.0549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5060 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5935 -6.0494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8409 -6.3817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3627 -4.3022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3310 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7455 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5705 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9810 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5705 -5.9418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7455 -5.9418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8102 -5.2290 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2206 -5.9418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6956 -5.9418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2852 -6.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4602 -6.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0456 -5.9418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4602 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0456 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4602 -3.7992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2852 -3.7992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6956 -4.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2852 -5.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1725 -6.6288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4684 -5.8552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9455 -5.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1307 -5.3436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8348 -6.1131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6120 -4.7011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3452 -6.7607 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7004 -7.2792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4011 -8.0616 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7046 -7.3798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2861 -8.1056 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.5423 -7.3793 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.1176 -8.1020 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.5935 -4.4087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
2 6 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
13 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
15 24 1 0
19 24 1 0
14 18 1 0
10 13 1 0
3 7 1 0
25 26 1 0
26 27 1 1
27 28 1 0
28 29 1 0
28 30 1 0
1 26 1 0
25 31 2 0
25 32 1 0
32 33 1 0
16 34 1 0
34 35 1 0
34 36 1 0
34 37 1 0
3 38 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 530.55Molecular Weight (Monoisotopic): 530.2141AlogP: 4.14#Rotatable Bonds: 8Polar Surface Area: 117.78Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.74CX Basic pKa: 7.46CX LogP: 3.69CX LogD: 3.51Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.30Np Likeness Score: -0.55
References 1. Argade A, Bahekar R, Desai J, Thombare P, Shah K, Gite S, Sunder R, Ranvir R, Bandyopadhyay D, Chakrabarti G, Joharapurkar A, Mahapatra J, Chatterjee A, Patel H, Shaikh M, Sairam KVVM, Jain M, Patel P. (2011) Design, synthesis and biological evaluation of -lactam hydroxamate based TACE inhibitors, 2 (10): [10.1039/C0MD00261E ]